GCA is an autoimmune disease that causes inflammation of the temporal and other cranial arteries, the aorta, and other large and medium arteries. If left untreated, the disease can lead to ...

GCA is an autoimmune disease that causes inflammation of the temporal and other cranial arteries, the aorta, and other large and medium arteries. The European Commission had recently granted ...

NORTH CHICAGO, Ill., April 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ ® (upadacitinib), 15 mg, once daily, for ...

This inflammatory condition affects the temporal arteries that supply blood to the head and brain. When these vessels become inflamed, they can cause significant pain, typically concentrated in ...

In temporal arteritis, the immune system attacks the blood vessels, especially the temporal artery, causing it to ... resulting in vasculitis (a term for inflammation of blood vessels).

Learn about eye changes that could indicate serious health conditions, from blurry vision to persistent floaters and flashes ...

Other symptoms appear nonspecific and are related to generalized inflammation ... The most specific finding is tender or thickened temporal arteries with decreased pulsations.

It is the memory-robbing disease that people fear the most as they age - and it is even more tragic when it strikes early.

The US Food and Drug Administration (FDA) has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA). The approval follows the recent marketing ...